Marc Duey serves as Executive at Aprea Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Marc Duey has executed 6 insider transactions totaling $25.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 10, 2025 involved purchasing 21,459 shares valued at $25.1K.
Marc Duey currently holds 256,155 shares of Aprea Therapeutics, Inc. (APRE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Marc Duey has been a net buyer of APRE stock. They have purchased $25.1K and sold $0 worth of shares.
Marc Duey's most recent insider trade was on Dec 10, 2025, when they purchased 21,459 shares at $1.17 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 23, 2023 | APRE | $0 | Award | 500 | $N/A | Discretionary |
| Aug 23, 2022 | APRE | $0 | Conversion | 4,009,690 | $N/A | Discretionary |
| Aug 23, 2022 | APRE | $0 | Conversion | 11,610 | $N/A | Discretionary |
| Jul 28, 2022 | APRE | $0 | Award | 5,995 | $N/A | Discretionary |